US Stock MarketDetailed Quotes

COGT Cogent Biosciences

Watchlist
  • 7.860
  • +0.100+1.29%
Close Dec 24 13:00 ET
  • 7.860
  • 0.0000.00%
Post 13:01 ET
868.23MMarket Cap-3.17P/E (TTM)

Cogent Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Cogent Biosciences Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Cogent Biosciences Earnings Reports

  • Cogent Biosciences | 10-Q: Q3 2024 Earnings Report

    Nov 12 12:49 ET

  • Cogent Biosciences | 8-K: Cogent Biosciences Reports Recent Business Highlights and Third Quarter 2024 Financial Results

    Nov 12 12:49 ET

  • Cogent Biosciences | 10-Q: Q2 2024 Earnings Report

    Aug 6 08:43 ET

  • Cogent Biosciences | 8-K: Cogent Biosciences Reports Recent Business Highlights and Second Quarter 2024 Financial Results

    Aug 6 08:23 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 18, 2024

    Strong Buy

    • Buy

      85.71%

    • Hold

      14.29%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data